Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review-Reference-Cited by-同舟云学术

Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review

Published:2020-09-21 Issue:10 Volume:64 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Stapleton Ann E.¹^ORCID,Wagenlehner Florian M. E.²^ORCID,Mulgirigama Aruni³,Twynholm Monique⁴

Affiliation:

1. Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA

2. Department of Urology, Pediatric Urology and Andrology, Justus Liebig University, Giessen, Germany

3. GSK Global Specialty and Primary Care, London, United Kingdom

4. GSK Medicines Research Centre, Stevenage, United Kingdom

Abstract

Antibiotic resistance is a threat to public health, and uncomplicated urinary tract infections (uUTIs) are an example of this concern. This systematic review (International Prospective Register of Systematic Reviews [PROSPERO] ID: CRD42020156674) is the first to determine the prevalence of Escherichia coli resistance to fluoroquinolones in women with community-acquired uUTI. PubMed and Embase searches were conducted; 38 studies fulfilled eligibility criteria and were included in the systematic review.

Funder

GlaxoSmithKline

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00862-20

Reference74 articles.

1. Epidemiology of urinary tract infections

2. Antibiotic-ResistantEscherichia coliin Women with Acute Cystitis in Canada

3. Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System